Our Medical Experts
Max Healthcare is home to 5000 eminent doctors in the world, most of whom are pioneers in their respective fields. Additionally, they are renowned for developing innovative and revolutionary clinical procedures.
Find a DoctorDelhi/NCR:
Mohali:
Dehradun:
Bathinda:
Mumbai:
Nagpur:
Lucknow:
BRAIN ATTACK:
To Book an Appointment
Call Us+91 92688 80303Getting diagnosed with multiple myeloma can be a life-altering experience. Patients often find themselves on a rollercoaster of emotions, grappling with fear and uncertainty. The urgency of this condition demands immediate medical intervention alongside compassionate support. At Max Hospitals, we understand the complexities of navigating multiple myeloma treatment. With a team of specialised experts, state-of-the-art technology, and personalised care plans, we are committed to delivering comprehensive treatment that addresses every aspect of your journey.
From diagnosis through recovery and beyond, our multidisciplinary approach ensures that our patients receive the highest standard of care. Whether you are seeking clarity on symptoms or exploring treatment options, our dedicated team is here to provide guidance and support every step of the way. Reach out to Max Hospitals today to access expert care and compassionate support tailored to your needs. Your journey to managing multiple myeloma begins here.
Multiple myeloma is a type of cancer that affects plasma cells, a type of white blood cell found in the bone marrow. Plasma cells are an essential part of the immune system, producing antibodies to help fight infections. In multiple myeloma, cancerous plasma cells multiply uncontrollably and produce abnormal proteins. This overproduction can lead to damage in the bones, immune system, kidneys, and red blood cell count.
The exact cause of multiple myeloma is not known. However, it involves genetic mutations that occur in plasma cells, leading them to grow and divide at an abnormally rapid rate. These changes can be influenced by a combination of genetic predispositions and environmental factors.
Several factors can increase the risk of developing multiple myeloma:
Symptoms of multiple myeloma can vary widely and may include:
Early detection and treatment are crucial in managing multiple myeloma, as the symptoms can often overlap with other conditions. If any of these symptoms are present, it is important to seek medical advice for proper diagnosis and management.
Diagnosing multiple myeloma typically involves a combination of the following tests and procedures:
Treatment for multiple myeloma depends on the stage of the disease, the patient’s overall health, and specific characteristics of the myeloma. Common treatments include:
Drugs like bortezomib, carfilzomib, and ixazomib target specific proteins in myeloma cells, helping to destroy them.
Medications like daratumumab, elotuzumab, and lenalidomide enhance the immune system's ability to fight myeloma cells.
Drugs like melphalan, cyclophosphamide, and doxorubicin are used to kill rapidly dividing myeloma cells.
Drugs such as dexamethasone and prednisone are used to reduce inflammation and are often combined with other treatments to enhance their effectiveness.
High-dose chemotherapy followed by a transplant of the patient's own stem cells (autologous stem cell transplant) to help rebuild healthy bone marrow.
Used to target and kill myeloma cells in specific areas, especially if there is a localised bone lesion causing pain or risk of fracture.
Treatments to manage symptoms and side effects, such as bisphosphonates (e.g., zoledronic acid) to strengthen bones, pain management strategies, and medications to protect kidney function.
Multiple myeloma is a type of blood cancer that affects plasma cells in the bone marrow. It can lead to various complications due to the abnormal plasma cells accumulating and interfering with the production and function of normal blood cells. Some common complications include:
While there is no sure way to prevent multiple myeloma, certain strategies may help reduce the risk or aid in early detection:
Routine medical check-ups can help detect abnormalities early. Blood tests, urine tests, and imaging studies can sometimes identify issues before they develop into serious complications.
Understanding and monitoring risk factors, such as age (most common in people over 60), gender (more common in men), race (more prevalent in African Americans), and family history of blood cancers, can help in early detection and intervention.
Reducing exposure to certain chemicals, pesticides, and radiation that are known to increase cancer risk can be beneficial.
Conditions such as monoclonal gammopathy of undetermined significance (MGUS) and smouldering myeloma can precede multiple myeloma. Regular monitoring and early intervention in these conditions can help manage the risk of progression to multiple myeloma.
While these steps can help manage risk, individuals need to consult healthcare professionals for personalised advice and regular screenings, especially if they have risk factors associated with multiple myeloma.
Chemotherapy for multiple myeloma works by using drugs to kill rapidly dividing myeloma cells, typically targeting their DNA or machinery involved in cell division. This helps to reduce the number of myeloma cells in the body and control the progression of the disease.
Multiple myeloma can affect the bones by causing bone destruction. Myeloma cells produce substances that stimulate osteoclasts, which are cells responsible for breaking down bone tissue. This leads to weakened bones, bone pain, fractures, and other skeletal complications.
Yes, multiple myeloma can lead to kidney problems. The abnormal proteins produced by myeloma cells can accumulate in the kidneys and cause damage over time, leading to kidney dysfunction or failure if left untreated.
Some lifestyle changes that can help manage multiple myeloma include maintaining a healthy diet, staying physically active as tolerated, managing stress levels, avoiding smoking and excessive alcohol consumption, and following medical advice regarding medications and treatments.
Multiple myeloma patients should see their doctor regularly as recommended by their healthcare team. This typically involves frequent check-ups, monitoring of blood tests and imaging studies, and adjustments to treatment plans as needed based on the patient's response and any new symptoms.
The prognosis for multiple myeloma can vary widely depending on factors such as the stage of the disease at diagnosis, the patient's overall health, and response to treatment. While multiple myeloma is generally considered incurable, advancements in treatment have significantly improved outcomes and life expectancy in recent years.
Common side effects of multiple myeloma treatments can include nausea, vomiting, fatigue, hair loss, bone marrow suppression leading to low blood cell counts, increased risk of infections, neuropathy (nerve damage), and gastrointestinal issues. The specific side effects can vary depending on the type of treatment used.
Multiple myeloma is typically not considered curable in the traditional sense, but many patients can achieve remission with treatment. Some patients may have long periods of remission where the disease is under control, while others may experience periods of relapse and require ongoing treatment.
Multiple myeloma is staged based on factors such as levels of abnormal proteins, calcium, and blood counts, as well as the presence of bone lesions and kidney function. The stages range from I (early stage with low levels of myeloma cells and minimal symptoms) to III (advanced stage with higher levels of myeloma cells and more severe symptoms).
Yes, although multiple myeloma is more commonly diagnosed in older adults, it can affect younger people as well. In younger individuals, the disease may present differently and treatment approaches may need to be tailored accordingly.
Genetics can play a significant role in multiple myeloma. Certain genetic mutations and abnormalities in plasma cells can increase the risk of developing the disease. Family history of multiple myeloma or related conditions like monoclonal gammopathy of undetermined significance (MGUS) can also contribute to the risk.
Multiple myeloma is not typically linked to other cancers in a direct causative manner. However, some individuals may have a higher risk of developing multiple myeloma if they have a history of other cancers or certain genetic predispositions.
MGUS stands for monoclonal gammopathy of undetermined significance. It is a condition where there is an abnormal protein (monoclonal protein or M protein) in the blood, but there are no other signs or symptoms of multiple myeloma or related disorders. MGUS can sometimes progress to multiple myeloma over time.
Long-term effects of multiple myeloma treatment can include bone density loss (osteoporosis), neuropathy (nerve damage), secondary cancers due to treatment, kidney damage, and effects related to stem cell transplants, such as infertility or hormonal changes. Monitoring and management of these effects are important for ongoing care.
Reviewed By Dr. Nivedita Dhingra - Associate Director - Medical Oncology (Haematology, Hemato–Oncology), Bone Marrow Transplant, Cancer Care / Oncology on 11 Nov 2024.
Max Healthcare is home to 5000 eminent doctors in the world, most of whom are pioneers in their respective fields. Additionally, they are renowned for developing innovative and revolutionary clinical procedures.
Max Healthcare is home to 5000 eminent doctors in the world, most of whom are pioneers in their respective fields. Additionally, they are renowned for developing innovative and revolutionary clinical procedures.
Find a Doctor